Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Cong, Rihong ^a   Sun, Qingmin ^a   Yang, Li ^a,b   Gu, Haijuan ^a   Zeng, Ying ^a   Wang, Bin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; COLLAGEN TYPE 1; GENISTEIN; MESSENGER RNA; ANTINEOPLASTIC AGENT; LEUKOCYTE ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE SECTION; UVEA MELANOMA; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; DRUG SCREENING; GENE EXPRESSION; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UVEA TUMOR;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, CD; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION; GENISTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UVEAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70349241687     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-124     Document Type: Article

References (39)

1. Clinical applications of research on angiogenesis. Seminars in Medicine of the Beth Israel Hospital, Boston. J Folkman, New Engl J Med 1995 333 1757 1763 10.1056/NEJM199512283332608 7491141
2. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. EV Getmanova Y Chen L Bloom J Gokemeijer S Shamah V Warikoo J Wang V Ling L Sun, Chem Biol 2006 13 549 556 10.1016/j.chembiol.2005.12.009 16720276
3. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. DW Van der Schaft RE Seftor EA Seftor AR Hess LM Gruman DA Kirschmann Y Yokoyama AW Griffioen MJ Hendrix, J Natl Cancer Inst 2004 96 1473 1477 15467037
4. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. AJ Maniotis R Folberg A Hess EA Seftor LMG Gardner J Pe'er JM Trent PS Meltzer MJC Hendrix, Am J Pathol 1999 155 739 752 10487832
5. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. N Sharma RE Seftor EA Seftor LM Gruman PM Heidger Jr MB Cohen DM Lubaroff MJ Hendrix, Prostate 2002 50 189 201 10.1002/pros.10048 11813211
6. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. K Shirakawa H Kobayashi Y Heike S Kawamoto MW Brechbiel F Kasumi T Iwanaga F Konishi M Terada H Wakasugi, Cancer Res 2002 62 560 566 11809710
7. Molecular determinants of ovarian cancer plasticity. AK Sood EA Seftor MS Fletcher LM Gardner PM Heidger RE Buller RE Seftor MJ Hendrix, Am J Pathol 2001 158 1279 1288 11290546
8. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. B Sun S Qie S Zhang T Sun X Zhao S Gao C Ni X Wang Y Liu L Zhang, Hum Pathol 2008 39 444 451 10.1016/j.humpath.2007.07.018 18261629
9. The biology of haematogenous metastasis in human uveal malignant melanoma. IW McLean, Virchows Arch A Pathol Anat Histopathol 1993 422 433 437 10.1007/BF01606450 8333146
10. Incidence of ocular melanoma in Australia from 1990 to 1998. CM Vajdic A Kricker M Giblin J McKenzie J Aitken GG Giles BK Armstrong, Int J Cancer 2003 105 117 122 10.1002/ijc.11057 12672041
11. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. JN Davis B Singh M Bhuiyan FH Sarkar, Nutr Cancer 1998 32 123 131 10.1080/01635589809514730 10050261
12. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. F Lian M Bhuiyan YW Li N Wall M Kraut FH Sarkar, Nutr Cancer 1998 31 184 191 10.1080/01635589809514701 9795970 (Pubitemid 28481852)
13. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. SA Alhasan H Pietrasczkiwicz MD Alonso J Ensley FH Sarkar, Nutr Cancer 1999 34 12 19 10.1207/S15327914NC340102 10453436
14. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). S Upadhyay M Neburi SR Chinni S Alhasan F Miller FH Sarkar, Clin Cancer Res 2001 7 1782 1789 11410520
15. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. MS Pepper SJ Hazel M Humpel WD Schleuning, Journal of Cellular Physiology 2004 199 98 107 10.1002/jcp.10460 14978739
16. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy. B Wang Y Zou H Li H Yan JS Pan ZL Yuan, J Ocul Pharmacol Ther 2005 21 107 113 10.1089/jop.2005.21.107 15857276
17. Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. B Wang Y Zou ZL Yuan JG Xiao, J Ocul pharmcol Ther 2003 19 457 464 10.1089/108076803322473015
18. Genistein inhibited hypoxia inducible factor-1 expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells. B Wang H Li JS Pan H Yan, Method Find Exp Clin Pharmacol 2005 27 179 184 10.1358/mf.2005.27.3.890875 (Pubitemid 40571212)
19. Inhibitive effect of genistein on hypoxia-induced basic fibroblast growth factor expression in human retinal pigment epithelium cells. JS Pan HJ Zhu B Zhang H Li H Yan B Wang, J Ocul Pharmacol Ther 2006 22 103 109 10.1089/jop.2006.22.103 16722796 (Pubitemid 43742946)
20. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. MJ Hendrix EA Seftor PS Meltzer LM Gardner AR Hess DA Kirschmann GC Schatteman RE Seftor, Proc Natl Acad Sci USA 2001 98 8018 8023 10.1073/pnas.131209798 11416160
21. Remodeling of the microenvironment by aggressive melanoma tumor cells. MJ Hendrix EA Seftor DA Kirschmann V Quaranta RE Seftor, Ann N Y Acad Sci 2003 995 151 161 10.1111/j.1749-6632.2003.tb03218.x 12814947
22. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. RE Seftor EA Seftor DA Kirschmann MJ Hendrix, Mol Cancer Ther 2002 1 1173 1179 12479698
23. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. J Wang Y Xu Y Xu H Zhu R Zhang G Zhang S Li, Cancer Invest 2008 26 359 368 10.1080/ 07357900701788106 18443956
24. Doxycycline influences microcirculation patterns in B16 melanoma. B Sun S Zhang D Zhang X Yin S Wang Y Gu Y Wang, Exp Biol Med (Maywood) 2007 232 1300 1307 10.3181/0705-RM-145 17959842
25. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. W Ruf EA Seftor RJ Petrovan RM Weiss LM Gruman NV Margaryan RE Seftor Y Miyagi MJ Hendrix, Cancer Res 2003 63 5381 5389 14500372
26. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. GD Basu LB Pathangey TL Tinder SJ Gendler P Mukherjee, Breast Cancer Res 2005 7 422 435 10.1186/bcr1019 15987447
27. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. AR Hess EA Seftor RE Seftor MJ Hendrix, Cancer Res 2003 63 4757 4762 12941789
28. Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. S Zhang M Li Y Gu Z Liu S Xu Y Cui B Sun, J Exp Clin Cancer Res 2008 27 60 10.1186/1756-9966-27-60 18983651
29. Genistein. RA Dixon D Ferreira, Phytochemistry 2002 60 205 211 10.1016/S0031-9422(02)00116-4 12031439
30. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. HG Farina M Pomies DF Alonso DE Gomez, Oncol Rep 2006 16 885 891 16969510
31. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. IR Record JL Broadbent RA King IE Dreosti RJ Head AL Tonkin, Int J Cancer 1997 72 860 864 10.1002/(SICI)1097-0215(19970904) 72:5<860::AID-IJC243.0.CO;2-B 9311605
32. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. M Boccellino G Camussi A Giovane L Ferro V Calderaro C Balestrieri L Quagliuolo, Am J Pathol 2005 166 1515 1522 15855650
33. Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. M Piao D Mori T Satoh Y Sugita O Tokunaga, Endothelium 2006 13 249 266 10.1080/10623320600903940 16990182
34. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. T Fotsis MS Pepper E Aktas S Breit S Rasku H Adlercreutz K Wahala R Montesano L Schweigerer, Cancer Res 1997 57 2916 2921 9230201
35. Presence of a fluidconducting meshwork in xenografted cutaneous and primary human uveal melanoma. R Clarijs I Otte-Höller DJ Ruiter RM de Waal, Invest Ophthalmol Vis Sci 2006 43 912 918
36. Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrastenhanced dynamic MRI with the macromolecular contrast agent G6-(1B4MGd)(256). H Kobayashi K Shirakawa S Kawamoto T Saga N Sato A Hiraga I Watanabe Y Heike K Togashi J Konishi MW Brechbiel H Wakasugi, Cancer Res 2002 62 860 866 11830544
37. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. AJ Maniotis X Chen C Garcia PJ DeChristopher D Wu J Pe'er R Folberg, Lab. Invest 2002 82 1031 1043 12177242
38. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. K Shirakawa H Wakasugi Y Heike I Watanabe S Yamada K Saito F Konishi, Int J Cancer 2002 99 821 828 10.1002/ijc.10423 12115483
39. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. K Shirakawa H Kobayashi Y Heike S Kawamoto MW Brechbiel F Kasumi T Iwanaga F Konishi M Terada H Wakasugi, Cancer Res 2002 62 560 566 11809710